Меклаквалон

Mecloqualone is a quinazolinone-class GABAergic and is an analogue of methaqualone that was first made in 1960 and marketed mainly in France and some other European countries. It has sedative, hypnotic, and anxiolytic properties caused by its agonist activity at the β subtype of the GABAa receptor, and was used for the treatment of insomnia. Mecloqualone is faster-acting but shorter-lasting than methaqualone and so was used only as a sleeping pill, in contrast to methaqualone, which was used as a general-purpose anxiolytic as well. Mecloqualone was never as widely used as methaqualone and is no longer prescribed because of concerns about its potential for abuse and overdose. In the United States it is a Schedule I non-narcotic (depressant) controlled substance with an ACSCN of 2572 and 30 grams annual aggregate manufacturing quota.

Classification

Chemical: Medicine
Chemical: Quinazolinone
Psychoactive: Depressant

Effects

Sedation
Motor Impairment
Muscle Relaxation
Physical Euphoria
Incoordination
Anxiolytic
Reduced Anxiety
Anxiety Suppression
Motor Control Loss
Amnesia
Thought Deceleration
Euphoria
Dulled Perception
Disinhibition
Blurred Vision
Increased Libido
Increased Music Appreciation
Changes In Felt Gravity

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

wikipedia.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu